Yeditepe University Faculty of Engineering, Department of Genetics and Bioengineering (Uzm.) Dr. Our project titled “In Vitro Cell (MDA-MB-231) and In Vivo Animal Model Evaluation of Nanoalgosomes Targeted with GE11 Peptide Co-Loaded with CendR and Doxorubicin as a Novel Chemotherapeutic Agent Against Triple Negative Breast Cancer” conducted by Tayfun Acar has been entitled to receive support within the scope of TÜBİTAK-ARDEB 2024 Year 1st Term 1001 Project Support Program. We congratulate the entire project team and wish them a successful and enjoyable project management process.